Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Frontiers in Bioengineering and Biotechnology|October 18, 2016
Fluid Dynamic Modeling to Support the Development of Flow-Based Hepatocyte Culture Systems for Metabolism StudiesJenny M Pedersen, Yoo-Sik Shim, Vaibhav Hans, et al.
Toxicology and Applied Pharmacology|May 22, 2018
An in vitro approach for prioritization and evaluation of chemical effects on glucocorticoid receptor mediated adipogenesisJessica K Hartman, Tyler Beames, Bethany Parks, et al.
The AAPS Journal|January 4, 2024
Use of the Same Model or Modeling Strategy Across Multiple Submissions: Focus on Complex Drug ProductsRoss L Walenga, Andrew H Babiskin, Sid Bhoopathy, et al.
Neurotoxicology|December 20, 2016
The application of PBPK models in estimating human brain tissue manganese concentrationsSiva P Ramoju, Donald R Mattison, Brittany Milton, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 12, 2022
Quantitative methods and modeling to assess COVID-19-interrupted in vivo pharmacokinetic bioequivalence studies with two reference batchesYuqing Gong, Kairui Feng, Peijue Zhang, et al.
Toxicology|August 18, 2020
Differential lymphatic versus portal vein uptake of the synthetic pyrethroids deltamethrin and cis-permethrin in ratsLarry G Higgins, Lynsey R Chatham, Sara L Tomczynski, et al.
ALTEX|October 31, 2019
Developing context appropriate toxicity testing approaches using new alternative methods (NAMs)Melvin E Andersen, Patrick D McMullen, Martin B Phillips, et al.
Environmental Research|December 23, 2019
Quantitative bias analysis of the association between subclinical thyroid disease and two perfluoroalkyl substances in a single studyMichael W Dzierlenga, Marjory Moreau, Gina Song, et al.
Clinical Pharmacology and Therapeutics|January 18, 2025
A 2024 Update on US FDA Implementation of Partial Area Under the Curve Into Bioavailability and Bioequivalence AssessmentsRobert Hopefl, Yuqing Gong, Elizabeth Bielski, et al.
Chemosphere|July 5, 2017
Using exposure prediction tools to link exposure and dosimetry for risk-based decisions: A case study with phthalatesMarjory Moreau, Jeremy Leonard, Katherine A Phillips, et al.
Pageof 8